SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-15-331175
Filing Date
2015-09-29
Accepted
2015-09-28 20:56:00
Documents
2
Group Members
ANNE-MARI PASTEROMEGA FUND IV GP MANAGER, LTD.OMEGA FUND IV GP, L.P.OMEGA FUND IV, L.P.OTELLO STAMPACCHIARICHARD LIM

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G d54196dsc13g.htm SC 13G 131228
2 EX-99.A d54196dex99a.htm EX-99.A 9768
  Complete submission text file 0001193125-15-331175.txt   142885
Mailing Address LEBERSTRASSE 20 VIENNA C4 1110
Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0
Nabriva Therapeutics AG (Subject) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89113 | Film No.: 151128706
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMICORP LUXEMBOURG S.A. 11-13, BOULEVARD DE LA FOIRE GRAND DUCHY OF LUXEMBOURG N4 L-1528
Business Address C/O AMICORP LUXEMBOURG S.A. 11-13, BOULEVARD DE LA FOIRE GRAND DUCHY OF LUXEMBOURG N4 L-1528 352 2627 43 1
Global Life Bioventure IV S.a.r.l. (Filed by) CIK: 0001652769 (see all company filings)

IRS No.: 000000000 | State of Incorp.: N4 | Fiscal Year End: 1231
Type: SC 13G